Table. 2.

Comparison of BPAR across the four subgroups

Variable Low-sensitized
non-DGF
Low-sensitized
DGF
Highly sensitized
non-DGF
Highly sensitized
DGF
BPAR 57 (12.1)b),c) 20 (18.3) 21 (20.4)a) 8 (29.6)a)
BPAR type
TCMR 38 (66.7) 14 (70.0) 6 (28.6) 4 (50.0)
ABMR 9 (15.8) 2 (10.0) 6 (28.6) 1 (12.5)
Mixed 6 (10.5) 1 (5.0) 0 2 (25.0)
Others 4 (7.0) 3 (15.0) 9 (42.9) 1 (12.5)
TCMR including mixed rejection 44 (9.4)c) 15 (13.8) 6 (5.8)c) 6 (22.2)a),b)
ABMR including mixed rejection 15 (3.2) 3 (2.8) 6 (5.8) 3 (11.1)

Values are presented as number (%); the percentage in the BPAR type is for the total number of BPARs. A total of 303 KTRs underwent allograft biopsy, of which BPAR was identified in 106 KTRs (35.0%). This is the result of BPAR which was confirmed at least once in KTRs who underwent repeated biopsy.

BPAR, biopsy proven acute rejection; DGF, delayed graft function; TCMR, T-cell-mediated rejection; ABMR, antibody-mediated rejection; KTR, kidney transplantation recipient.

a)P<0.05 vs. low-sensitized non-DGF; b)P<0.05 vs. highly sensitized non-DGF, c)P<0.05 vs. highly sensitized DGF.

Korean J Transplant 2021;35:149~160 https://doi.org/10.4285/kjt.21.0014
© Korean Journal of Transplantation